X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
braf inhibitors (3) 3
index medicus (3) 3
abridged index medicus (2) 2
brafv600 mutation (2) 2
circulating tumor dna (2) 2
corticoids (2) 2
corticosteroids (2) 2
life sciences (2) 2
metastatic melonoma (2) 2
patients (2) 2
1506 (1) 1
2016 update (1) 1
adolescent (1) 1
adrenal cortex hormones - adverse effects (1) 1
adrenal cortex hormones - therapeutic use (1) 1
arthritis (1) 1
arthritis, juvenile - complications (1) 1
arthritis, juvenile - drug therapy (1) 1
baseline genomic alterations (1) 1
body height (1) 1
body height - drug effects (1) 1
body-composition (1) 1
braf inhibitor (1) 1
c-reactive protein (1) 1
catch-up growth (1) 1
child (1) 1
children (1) 1
citrulline (1) 1
clinical trials (1) 1
clinical-practice (1) 1
confidence intervals (1) 1
correspondence (1) 1
determinants (1) 1
dmards (1) 1
endocrinology & metabolism (1) 1
epidemiology (1) 1
eular recommendations (1) 1
factor-i (1) 1
female (1) 1
final height (1) 1
follow-up (1) 1
follow-up studies (1) 1
growth - drug effects (1) 1
growth hormone (1) 1
hormone treatment (1) 1
human growth hormone - therapeutic use (1) 1
human health and pathology (1) 1
humans (1) 1
igf binding protein-3 (1) 1
inflammation - complications (1) 1
inflammatory arthritis (1) 1
inflammatory cytokines (1) 1
joint destruction (1) 1
lef protein (1) 1
low-dose prednisolone (1) 1
male (1) 1
medical research (1) 1
mek inhibitor (1) 1
melanoma (1) 1
metastatic melanoma (1) 1
modifying antirheumatic drugs (1) 1
parents (1) 1
peptides (1) 1
pharmacology (1) 1
physical growth (1) 1
population studies (1) 1
prediction models (1) 1
predictive analysis (1) 1
prospective studies (1) 1
randomized-trial (1) 1
regression analysis (1) 1
research paper (1) 1
rheumatoid arthritis (1) 1
rheumatoid-arthritis (1) 1
rheumatology (1) 1
rhumatology and musculoskeletal system (1) 1
sexual maturation (1) 1
smallest detectable difference (1) 1
statistical analysis (1) 1
statistics (1) 1
steroid-therapy (1) 1
targeted genomic alteration (1) 1
targeted therapy resistance (1) 1
therapy (1) 1
transgenic mice (1) 1
treatment outcome (1) 1
variables (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 08/2019, Volume 69, Issue 2, pp. 189 - 193
OBJECTIVES:In adult inflammatory bowel disease (IBD) treated by anti-TNF antibodies, paradoxical psoriasis has an estimated prevalence of 1.6 to 22%,... 
Index Medicus
Journal Article
Cancers, ISSN 2072-6694, 08/2019, Volume 11, Issue 8, p. 1203
In metastatic melanoma, the combination of BRAF and MEK inhibitors (BRAFi, MEKi) has undergone multiple resistance mechanisms, limiting its clinical benefit... 
BRAF inhibitor | MEK inhibitor | metastatic melanoma | baseline genomic alterations
Journal Article
Oncotarget, ISSN 1949-2553, 03/2019, Volume 10, Issue 18, pp. 1669 - 1687
Several mechanisms have been described to elucidate the emergence of resistance to MAPK inhibitors in melanoma and there is a crucial need for biomarkers to... 
Journal Article
ESMO Open, ISSN 2059-7029, 09/2017, Volume 2, Issue 2, pp. e000173 - e000173
Click here to see the linked article 
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.